TY - JOUR
T1 - Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study
T2 - a first report from the C-NET STUDY
AU - The C-NET STUDY Group
AU - Sekiguchi, Masau
AU - Hotta, Kinichi
AU - Takeuchi, Yoji
AU - Tanaka, Shinji
AU - Yamamoto, Hironori
AU - Shinmura, Kensuke
AU - Harada, Keita
AU - Uraoka, Toshio
AU - Hisabe, Takashi
AU - Sano, Yasushi
AU - Kondo, Hitoshi
AU - Horimatsu, Takahiro
AU - Kikuchi, Hidezumi
AU - Kawamura, Takuji
AU - Nagata, Shinji
AU - Yamamoto, Katsumi
AU - Tajika, Masahiro
AU - Tsuji, Shigetsugu
AU - Kusaka, Toshihiro
AU - Okuyama, Yusuke
AU - Yoshida, Naohisa
AU - Moriyama, Tomohiko
AU - Hasebe, Aki
AU - So, Suketo
AU - Kobara, Hideki
AU - Kashida, Hiroshi
AU - Miyanaga, Ryoichi
AU - Kato, Sosuke
AU - Hayashi, Yoshito
AU - Sada, Miwa
AU - Fukuzawa, Masakatsu
AU - Kato, Hiroyuki
AU - Takayama, Tetsuji
AU - Konishi, Jun
AU - Matsushita, Hiro o.
AU - Narasaka, Toshiaki
AU - Ohata, Ken
AU - Togashi, Kazutomo
AU - Nakamura, Hisashi
AU - Moriichi, Kentaro
AU - Oda, Yasushi
AU - Kanda, Naoki
AU - Kuwai, Toshio
AU - Terai, Shuji
AU - Sanomura, Makoto
AU - Kitamura, Shinji
AU - Miyamoto, Hayato
AU - Kiriyama, Shinsuke
AU - Mizuno, Chiemi
AU - Saito, Yutaka
N1 - Funding Information:
This study was supported by the Japan Agency for Medical Research and Development (AMED; JP16ck0106102, JP19ck0106276).
Publisher Copyright:
© 2022, Japanese Society of Gastroenterology.
PY - 2022
Y1 - 2022
N2 - Background: This is the first report from a multicenter prospective cohort study of colorectal neuroendocrine tumor (NET), the C-NET STUDY, conducted to assess the long-term outcomes of the enrolled patients. This report aimed to elucidate the clinicopathological features of the enrolled patients and lesions. Methods: Colorectal NET patients aged 20–74 years were consecutively enrolled and followed up at 50 institutions. The baseline characteristics and clinicopathological findings at enrollment and treatment were assessed. Results: A total of 495 patients with 500 colorectal NETs were included. The median patient age was 54 years, and 85.3% were asymptomatic. The most frequent lesion location was the lower rectum (88.0%); 99.4% of the lesions were clinically diagnosed to be devoid of metastatic findings, and 95.4% were treated with endoscopic resection. Lesions < 10 mm comprised 87.0% of the total, 96.6% had not invaded the muscularis propria, and 92.6% were classified as WHO NET grade 1. Positive lymphovascular involvement was found in 29.2% of the lesions. Its prevalence was high even in small NETs with immunohistochemical/special staining for pathological assessment (26.4% and 40.9% in lesions sized < 5 mm and 5–9 mm, respectively). Among 70 patients who underwent radical surgery primarily or secondarily, 18 showed positive lymph node metastasis. Conclusions: The characteristics of real-world colorectal NET patients and lesions are elucidated. The high positivity of lymphovascular involvement in small NETs highlights the necessity of assessing the clinical significance of positive lymphovascular involvement based on long-term outcomes, which will be examined in later stages of the C-NET STUDY. Trial registration number: UMIN000025215.
AB - Background: This is the first report from a multicenter prospective cohort study of colorectal neuroendocrine tumor (NET), the C-NET STUDY, conducted to assess the long-term outcomes of the enrolled patients. This report aimed to elucidate the clinicopathological features of the enrolled patients and lesions. Methods: Colorectal NET patients aged 20–74 years were consecutively enrolled and followed up at 50 institutions. The baseline characteristics and clinicopathological findings at enrollment and treatment were assessed. Results: A total of 495 patients with 500 colorectal NETs were included. The median patient age was 54 years, and 85.3% were asymptomatic. The most frequent lesion location was the lower rectum (88.0%); 99.4% of the lesions were clinically diagnosed to be devoid of metastatic findings, and 95.4% were treated with endoscopic resection. Lesions < 10 mm comprised 87.0% of the total, 96.6% had not invaded the muscularis propria, and 92.6% were classified as WHO NET grade 1. Positive lymphovascular involvement was found in 29.2% of the lesions. Its prevalence was high even in small NETs with immunohistochemical/special staining for pathological assessment (26.4% and 40.9% in lesions sized < 5 mm and 5–9 mm, respectively). Among 70 patients who underwent radical surgery primarily or secondarily, 18 showed positive lymph node metastasis. Conclusions: The characteristics of real-world colorectal NET patients and lesions are elucidated. The high positivity of lymphovascular involvement in small NETs highlights the necessity of assessing the clinical significance of positive lymphovascular involvement based on long-term outcomes, which will be examined in later stages of the C-NET STUDY. Trial registration number: UMIN000025215.
KW - Colonoscopy
KW - Colorectal neuroendocrine tumors
KW - Endoscopic resection
KW - Lymphovascular involvement
UR - http://www.scopus.com/inward/record.url?scp=85131857611&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131857611&partnerID=8YFLogxK
U2 - 10.1007/s00535-022-01877-5
DO - 10.1007/s00535-022-01877-5
M3 - Article
C2 - 35554678
AN - SCOPUS:85131857611
SN - 0944-1174
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
ER -